September 18, 2025

Pathophysiology of Myasthenia Gravis – NeurologyLive

September 18, 2025

Treatment Strategies in Seronegative and Other Patients With Myasthenia Gravis – NeurologyLive

September 18, 2025

Promising Early Efgartigimod Response Data for Generalized Myasthenia Gravis – The American Journal of Managed Care

September 17, 2025

Results of China Phase III Clinical Study of Telitacicept for Generalized Myasthenia Gravis Selected for Oral Presentation at 2025 AANEM Annual Meeting – PR Newswire

September 15, 2025

Dr. James F. Howard Jr. leads groundbreaking study in myasthenia gravis treatment – NC TraCS Institute